With the biomarker assessment module of the TIDE website, we evaluated the accuracy of PES1 in five ICB HNSCC cohorts and compared it with other published biomarkers associated with tumor immune evasion, including CD274 (PD‐L1), MSI Score, CD8, Merck18, and IFNG. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.